Prostate Cancer Trials

The prostate gland exists in men at the base of the bladder. There is a one in six chance of a man developing prostate cancer, but it can often be cured. Once prostate cancer spreads is it usually incurable. Treatment can range from surgery to chemotherapy to 'active surveillance'. Clinical trials are important to move many of these treatments forward. Read more about Prostate Cancer.

Prostate cancer is the most common cancer in Australia. It can often be cured but if it spreads it can be very deadly.

The purpose of this study is to see if a new tablet drug, darolutamide, combined with the current best treatments, can improve outcomes for men with high risk prostate cancer that has not spread beyond the prostate area.

The purpose of this clinical trial is to compare the effectiveness of Lu-PSMA therapy followed by docetaxel chemotherapy versus docetaxel chemotherapy on its own.

 

The NINJA clinical trial aims to compare two emerging schedules of radiotherapy in the treatment of intermediate or high risk prostate cancer. 

The ExerciseGuide is looking to determine whether an 8-week website-based exercise plus phone support program is safe, acceptable and feasible for men with metastatic prostate cancer.

The ENZAMET trial was for men with metastatic prostate cancer commencing androgen deprivation therapy. This trial is now in follow up.

 

The ENZARAD trial was for men with localised prostate cancer at high risk for recurrence deemed suitable for external beam radiation therapy. This trial is now in follow up.

This randomised study compared radionuclide therapy, Lu-PSMA, with a type of chemotherapy called cabazitaxel, which is the standard treatment for advanced prostate cancer when other treatments have stopped working. This trial is now in follow up..

This clinical trial investigated a new type of scan which provides whole body images of prostate cancer spread. This trial is now in follow up.

 

This trial was for men with localised prostate cancer at high risk for recurrence deemed suitable for external beam radiation therapy. This trial is now in follow up.

© ANZUP 2020. All rights reserved.